VIM and breast cancer: Overexpression of miR-138-5p targets rhomboid domain-containing protein 1 and significantly inhibits the invasion, migration, and epithelial-mesenchymal transition (EMT) of breast cancer cells by upregulating E-cadherin expression and downregulating N-cadherin and vimentin [23].